生物活性：Liraglutide-13C5,15N (tetraTFA) is the 13C and 15N labeled Liraglutide (HY-P0014)[1]. Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist used clinically to treat type 2 diabetes mellitus[2].
体外研究(In Vitro)：氢、碳和其他元素的稳定重同位素已被纳入药物分子中，主要作为药物开发过程中定量的示踪剂。氘化引起了人们的关注，因为它可能影响药物的药代动力学和代谢谱[1]。
德尔塔生物 has not independently confirmed the accuracy of these methods. They are for reference only.
Liraglutide-13C5,15N TFA 相关抗体:
GLP-1R Antibody
Glucagon Antibody
gamma Sarcoglycan Antibody (YA1357)
delta Sarcoglycan Antibody (YA3326)
分子量：3757.16 (free acid)
Formula：C16713C5H265N4215NO51.xC2HF3O2
非标记 CAS：204656-20-2
性状：固体
颜色：White to off-white
Sequence
His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-{Val-13C5,15N}-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-{Lys-N6-[N-(1-oxohexadecyl)-L-g-glutamyl]}-Glu-Phe-Ile-Ala-Trp-Leu-Val-Arg-Gly-Arg-Gly (TFA salt)
Sequence Shortening
HAEGTFTSD-{Val-13C5,15N}-SSYLGQAA-{Lys-N6-[N-(1-oxohexadecyl)-L-g-glutamyl]}-EFIAWLVRGRG (TFA salt)
中文名称：利拉鲁肽-13C5,15N
运输条件：Room temperature in continental US; may vary elsewhere.
储存方式：Sealed storage, away from moisture
Powder：-80°C：2 years
-20°C：1 year
*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)